Global Injectable Drugs Market 2017-2021 - Product Image

Global Injectable Drugs Market 2017-2021

  • ID: 4339873
  • Report
  • Region: Global
  • 84 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • AbbVie
  • Bayer
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche
  • GlaxoSmithKline
  • Merck
  • MORE
About Injectable Drugs

Injectable drugs are directly infused into the body with the help of a syringe and a hollow needle. Various modes of infusion are used for the drug delivery. Among them, subcutaneous (SC), intramuscular (IM), and intravenous (IV) are the three major modes. The market encompasses drugs that are used for the prevention and cure of various diseases, and are mainly of two types, namely, biologics and small molecule drugs.

The analysts forecast the global injectable drugs market to grow at a CAGR of 8.21% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global injectable drugs market for 2017-2021. To calculate the market size, the report considers the sales of vaccines, branded, generic, and off-label drugs.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, Global Injectable Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • AbbVie
  • F. Hoffmann-La Roche
  • GlaxoSmithKline
  • Sanofi
Other prominent vendors
  • Bayer
  • Bristol-Myers Squibb
  • Merck
  • Takeda Pharmaceutical
  • Teva Pharmaceutical
Market drivers
  • Escalation in demand for self-injection devices
  • For a full, detailed list, view the full report
Market challenges
  • High cost of production
  • For a full, detailed list, view the full report
Market trends
  • Increase in industry-academia collaboration
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the Key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AbbVie
  • Bayer
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche
  • GlaxoSmithKline
  • Merck
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
  • Market outline
  • ROA
PART 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 06: Pipeline landscape

PART 07: Market segmentation by molecule type
  • Biologics
  • Small molecules
PART 08: Geographical segmentation
  • Injectable drugs market in Americas
  • Injectable drugs market in EMEA
  • Injectable drugs market in APAC
PART 09: Decision framework

PART 10: Drivers and challenges
  • Market drivers
  • Market challenges
PART 11: Market trends
  • Rising awareness leading to high demand for injectable drugs
  • Increase in industry-academia collaboration
  • Expected entry of novel vaccines
  • Advent of biosimilars
PART 12: Vendor landscape
  • Competitive landscape
PART 13: Key vendor analysis
  • AbbVie
  • F. Hoffmann-La Roche
  • GlaxoSmithKline
  • Sanofi
  • Other prominent vendors
PART 14: Appendix
  • List of abbreviations
List of Exhibits
Exhibit 01: Market scenario: Global injectable drugs market 2016
Exhibit 02: Decisive factors for the choice of ROA
Exhibit 03: Major ROA for drugs intake
Exhibit 04: Types of injections
Exhibit 05: Adverse effects of injectable drugs
Exhibit 06: Global injectable drugs market snapshot
Exhibit 07: Global injectable drugs market 2016-2021 ($ billions)
Exhibit 08: Opportunity analysis in global injectable drugs market
Exhibit 09: Five forces analysis
Exhibit 10: Pipeline molecules by key vendors (Phase III)
Exhibit 11: Key clinical trials of key vendors (Phase III)
Exhibit 12: Global injectable drugs market segmentation by molecule type
Exhibit 13: Global injectable drugs market segmentation by molecule type 2016 and 2021 (%)
Exhibit 14: Global biologics injectable drugs market 2016-2021 ($ billions)
Exhibit 15: Top biologic drugs in the injectable drugs market
Exhibit 16: Global small molecules injectable drugs market 2016-2021 ($ billions)
Exhibit 17: Segmentation of global injectable drugs market based on geography 2016 and 2021 (%)
Exhibit 18: Global injectable drugs market by geography 2016-2021 ($ billions)
Exhibit 19: Market scenario in Americas
Exhibit 20: Injectable drugs market in Americas 2016-2021 ($ billions)
Exhibit 21: Market scenario in EMEA
Exhibit 22: Injectable drugs market in EMEA 2016-2021 ($ billions)
Exhibit 23: Market scenario in APAC
Exhibit 24: Injectable drugs market in APAC 2016-2021 ($ billions)
Exhibit 25: Major indications finding huge applications of injectable drugs
Exhibit 26: Major reasons to use injectable drugs
Exhibit 27: New cases of diabetes by 2040
Exhibit 28: Major complications involved with the injections
Exhibit 29: Major causes of drug shortage
Exhibit 30: Competitive structure analysis of global injectable drugs market
Exhibit 31: AbbVie: Key highlights
Exhibit 32: AbbVie: Strength assessment
Exhibit 33: AbbVie: Strategy assessment
Exhibit 34: AbbVie: Opportunity assessment
Exhibit 35: F. Hoffmann-La Roche: Key highlights
Exhibit 36: F. Hoffmann-La Roche: Strength assessment
Exhibit 37: F. Hoffmann-La Roche: Strategy assessment
Exhibit 38: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 39: GlaxoSmithKline: Key highlights
Exhibit 40: GlaxoSmithKline: Strength assessment
Exhibit 41: GlaxoSmithKline: Strategy assessment
Exhibit 42: GlaxoSmithKline: Opportunity assessment
Exhibit 43: Sanofi: Key highlights
Exhibit 44: Sanofi: Strength assessment
Exhibit 45: Sanofi: Strategy assessment
Exhibit 46: Sanofi: Opportunity assessment
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • AbbVie
  • Bayer
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche
  • GlaxoSmithKline
  • Merck
  • MORE
New Report Released: – Global Injectable Drugs Market 2017-2021

The author of the report recognizes the following companies as the key players in the global injectable drugs market: AbbVie, F. Hoffmann-La Roche, GlaxoSmithKline, and Sanofi.

Other Prominent Vendors in the market are: Bayer, Bristol-Myers Squibb, Merck, Takeda Pharmaceutical, and Teva Pharmaceutical.

Commenting on the report, an analyst from the research team said: “One trend in the market is increase in industry-academia collaboration. The key players in the injectable drugs market, especially vaccines market, are increasingly extending their support to academic institutions to support the R&D of innovative products for diabetes care. Such collaborations enable the amalgamation of research expertise of academic institutions with the marketing intelligence of pharma companies, besides providing funds for conducting the trial studies.”

According to the report, one driver in the market is escalation in demand for self-injection devices. There has been a rise in the demand for self-injection devices in the recent years, owing to the factors such as the high demand for diabetes and other hormone replacement therapies. Diabetes is turning to be one of the most serious health concerns in the people across the world. It was estimated that, in 2015, approximately 400-425 million of the adult population were having diabetes. If this uncontrolled blood sugar stays for a longer period, it can affect the quality of life and can even lead to a slow death in longer duration. For instance, around 1.45 million people die due to diabetes each year.

Further, the report states that one challenge in the market is high cost of production. The injectable drugs come up with high operational costs, which further increases the final cost of the products. There are a large number of factors, which contribute to the high price of the injectable drugs, more specifically the vaccines. It was estimated that the development of a single vaccine costs around $1 billion-$2 billion. High failure rates associated with vaccine development are majorly responsible for the increased production cost of the vaccines. The approval rate by the FDA is extremely low compared with the number of molecules present in the clinical trials.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • AbbVie
  • F. Hoffmann-La Roche
  • GlaxoSmithKline
  • Sanofi
  • Bayer
  • Bristol-Myers Squibb
  • Merck
  • Takeda Pharmaceutical
  • Teva Pharmaceutical
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll